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To describe the spectrum of pathogens isolated from Chinese women experiencing premature rupture of
the membranes (PROM) and those of their neonates, in order to provide effective management of PROM.
We searched Ovid Medline, Chinese Biomedical Literature Database, China National Knowledge Infra-
structure, and VIP Database for Chinese Technical Periodicals up to April 2012. The quality of studies was
assessed utilizing the Strengthening the Reporting of Observational Studies in Epidemiology Statement.
Among the included 36 studies, 11 (30.55%) were deemed to be at Level A, 12 (33.33%) at Level B, three
(8.33%) at Level C, and 10 (27.78%) at Level D. Staphylococcus and Escherichia coli were the two primary
microorganisms isolated from women with PROM and their infants. Subgroup analysis showed the
distribution of microorganisms from the six regions of China varied. Staphylococcus bacteria were
resistant to penicillins, except oxacillin, but more sensitive to ﬁrst- and second-generation cephalo-
sporins. Escherichia were sensitive to ﬁrst- and second-generation cephalosporins and were more sen-
sitive to aztreonam than cephalosporins. The main pathogens derived fromwomenwith PROM and their
newborns were Staphylococcus and E. coli, which differs from the pathogens in Western countries. Hence,
one might infer that the pathogens involved in PROM should be deﬁned in each region to maximize
antibiotic effectiveness. In addition, randomized controlled studies are needed to compare prophylactic
use of antibiotics versus use of antibiotics after a positive culture for newborn infants with a history of
PROM.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Thedeﬁnition of premature rupture of themembranes (PROM) is
rupture of membranes prior to the onset of labor [1]. Membrane
rupture that occurs before 37 weeks of gestation is referred to as
preterm premature rupture of membranes (PPROM) [1]. PROM oc-
curs in about 8% of pregnant women worldwide [2e4]. A report
from Mainland China found that the incidence of PROM was
signiﬁcantly higher at 19.5% [5]. PROM presents in 30e40% ofniversity Hospital, Sichuan
, Chengdu, China.
bstetrics & Gynecology. Publishedpreterm births, and is the most common cause of deliveries occur-
ring between 20 weeks and 37 weeks of gestation [6]. In addition,
prematurity and low birth weight are leading causes of neonatal
death (31%) in the world [7]. Determining the most efﬁcacious
method tomanagePROM in order tominimize its adverse impact on
newborns is necessary and paramount to a positive outcome.
Infection can be associated with PROM as either a cause or a
consequence [8]. Current literature has identiﬁed a broad range of
organisms present in amniotic ﬂuid specimens after PROM [9e11].
In the USA and Canada, Group B Streptococci (GBS) appears to be
the microorganism that colonizes the majority of pregnant women
with PROM [12,13]. It is also the primary causative agent associated
with PPROM [14e16]. Guidelines issued by these two countriesby Elsevier Taiwan LLC. All rights reserved.
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with PROM.
However, the distribution of microorganisms associated with
PROM in pregnant women and neonates in China is still uncertain.
Although there are studies investigating microorganisms in Chi-
nese women with PROM and their neonates, all of them were car-
ried out in single hospitals with limited sample sizes. The purpose
of this study is to describe the spectrum of pathogens in this group
of Chinese mothers and neonates by a systematic review. The re-
sults may aid in choosing the most appropriate antibiotic in the
management of PROM in China.
Materials and methods
Search strategy
We searched Ovid Medline, Chinese Biomedical Literature
Database (1989e2012), China National Knowledge Infrastructure
(1979e2012), and VIP Database for Chinese Technical Periodicals
(1989e2012) using the keywords: premature rupture of membranes,
microbiological, pathogenesis, and etiology, without limitation of
language. The references of eligible studies were also searched.
Criteria for considering studies for this review
Types of participants: pregnant women diagnosed with PROM
and their newborns.
Types of specimens: mothers: cervical secretions, vaginal
discharge, amniotic ﬂuid, placenta or blood sample; neonates:
mouth and throat swabs or blood sample.
Types of outcomes: categories and antimicrobial susceptibility
of microorganisms isolated from mothers with PROM and/or their
infants.
Study designs: prospective or retrospective studies.
Quality assessment and data collection
Two authors (L.-l.Z., L.-l. Gu) independently performed quality
assessments. Seven items were used to assess the quality of studies
based on the STROBE (Strengthening the Reporting of Observa-
tional Studies in Epidemiology) Statement [17,18]. These seven
items were: (1) whether the study reported study period; (2)
source of participants; (3) inclusion and exclusion criteria; (4) type
of specimens (e.g., cervical secretions) and the method of collec-
tion; (5) method of pathogen detection; (6) whether the study
performed antimicrobial susceptibility testing and reported its
method of antimicrobial susceptibility testing; and (7) complete-
ness of outcome data. A study received one point for each item.
The total potential score is 7 for each study. Therefore, Level A
scored 6e7, Level B scored 5e6, Level C scored 4e5, and Level D
scored <4. Dissension was resolved by discussion with a third
person (L.-l.Z.).
Two authors (L.-n. Zeng, L.-l. Gu) independently extracted the
following data from the included studies: study period, institution,
region of institution, sample size, type of specimens, characteristics
of patients (gestational age in weeks, length of PROM, whether or
not prophylactic antibiotics were administered), categories and
number of microorganisms, and the antimicrobial susceptibility of
microorganisms. We classiﬁed microorganisms according to Ber-
gey's Manual of Systematic Bacteriology [19].
Data analysis
To determine the predominant microbial pathogens in pregnant
women with PROM and their infants in China, descriptive datareported as continuous variables were expressed as ranges or
medians with interquartile ranges. Data reported as categorical
variables are expressed as a number or percentage.
Results
Characteristics of included studies
We included a total of 36 studies (Fig. 1; Table 1) [20e56]. Of
these, 31 took specimens from mothers and six from neonates.
Studies were from south China (27.77%, 10/36), north China
(22.22%, 8/36), and central China and east China (16.67%, 6/36,
respectively); one was from northwest China (2.77%). The sample
sizes varied from 5 to 3432 (median: 53, interquartile: 32e100).
Most studies collected cervical secretions (44.44%,16/36) or vaginal
secretions (27.77%, 10/36) to detect colonized microorganisms. The
pathogen positive rates varied among studies (9.55e100% in
mothers and 7.60e72.77% in neonates). The positive rates of aer-
obes were 10.53e62.5%, while that of anaerobes and mycoplasma
were 12.5e91.7% and 5.26e45.16% respectively.
Quality assessment of included studies
Quality assessments were as follows: 11 studies (30.55%) scored
at Level A, 12 (33.33%) studies scored at Level B, three (8.33%)
studies scored at Level C and 10 (27.78%) studies scored at Level D
(Table 2). Two signiﬁcant problems that emerged were: lack of
antimicrobial susceptibility testing and incomplete outcomes data.
Only three (8.33%) studies performed both antimicrobial suscepti-
bility testing and reported the methods.
The predominant microbial agents in PROM
Microorganisms isolated from mothers with PROM in China
(1980e2012)
From 3782 mothers, 1706 isolates were obtained. Gram-positive
bacteria were the predominant microbial organisms (54%), while
Gram-negative bacteria made up 23% (Fig. 2). The top six bacteria
isolated were Staphylococcus (n ¼ 643), Escherichia (n ¼ 204),
Enterococcus (n ¼ 88), Lactobacillus (n ¼ 78), Enterobacter (n ¼ 61),
and Streptococcus (n ¼ 60). Among Gram-positive bacteria, Staph-
ylococcuswas themost frequently isolated organism (n¼ 643, 70%),
followed by Enterococcus (n¼ 88,10%) and Lactobacillus (n¼ 78, 8%;
Fig. 3). The primary Gram-negative bacteria isolated were Escher-
ichia (n ¼ 204, 53%), Enterobacter (n ¼ 31, 8%), and Gardnerella
(n¼ 20, 5%; Fig. 4). The fungal isolates were primarily Candida (86%;
Fig. 5). The main anaerobe was Bacteroides (37%; Fig. 6).
Eleven studies of intrauterine cultures (amniotic ﬂuid or
placenta) were sub-analyzed and the results were consistent with
data from the full analysis set: the predominant Gram-positive
organism was Staphylococcus (n ¼ 77, 48%), while the predomi-
nant Gram-negative organisms were Enterobacter (n¼ 29, 34%) and
Escherichia (n ¼ 18, 21%).
Microorganisms isolated from neonates with PROM in China
(1980e2012)
Six studies cultured specimens from neonates born to mothers
with PROM. Three of them reported categories of all microorgan-
isms [43,46,47] (Table 3) and showed that Staphylococcus was the
main pathogen in affected neonates. The others did not report all
categories of microorganisms, but showed that Staphylococcus
aureus and E. coli were the main pathogens.
Among these three studies, a study 47 of central cultures (blood
samples) with a large sample size (n ¼ 3432) showed the overall
positive rate of blood culture was 7.6% in newborns with PROM.
Fig. 1. Flow diagram of inclusion and exclusion of literature.
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bacilli made up 33.8%. The most common organisms included
Staphylococcus, Klebsiella, and Escherichia, accounting for 75.8% of
the total patients with a positive blood culture.Factors that may affect the distribution of colonized strains in
mothers and neonates with PROM
Region
Distribution of strains varied among different regions of China
(Fig. 7). In north, southwest, and south China Gram-positive cocci
were the main strains, followed by Gram-negative bacilli. In central
and northwest China, anaerobes comprised the greatest percent-
age. In east China, Gram-positive bacilli were more prevalent than
in other regions.
Prophylactic antibiotics
Lin et al [30] assessed the inﬂuence of prophylactic antibiotics
on colonized strains in mothers with PROM. No signiﬁcant differ-
ence was found between the prophylactic antibiotic group and the
control group [30].Drug sensitivity of predominant bacteria colonizing mothers and
neonates with PROM
Nine studies reported the results of antimicrobial susceptibility
tests. Most of the Staphylococcus, including S. aureus and Staphy-
lococcus epidermidis were resistant to penicillins (66.34e100%),
except oxacillin (40e60%). Staphylococcus with resistance to the
ﬁrst and second generation cephalosporins ranged from 29.49% to
71.58%. The isolated Staphylococcuswere more sensitive to the third
generation cephalosporins. Reported drug resistance rates ranged
from 21.78% to 23.08%. In terms of aminoglycosides, all staphylo-
cocci were resistant to streptomycin, and 40e50% were resistant to
gentamicin. Streptococcus appeared to be sensitive to penicillins,
and ﬁrst and second generation cephalosporins with drug resis-
tance rates ranging from 33% to 40%. Drug resistance rates of
Escherichia were 23.3e90.27% to penicillins and 4.35e38.589% to
the ﬁrst and second cephalosporins. Escherichiawas more sensitive
to aztreonam with drug resistance rates ranging from 0% to 35.4%.There were no drug sensitivity data for Enterococcus, Enterobacter,
and Klebsiella.
Discussion
Distribution of colonized bacteria following PROM
In the Chinese population, pathogens derived fromwomenwith
PROM were predominantly Staphylococcus and Escherichia. The
colonization or cause of sepsis in their infants were primarily
Staphylococcus, Klebsiella pneumonia, and Escherichia. This bacterial
pattern differs from the pattern in western countries where GBS
constitutes most of the isolates from women with PROM and their
babies. Thus, geographical regions can inﬂuence the organisms
cultured from women with PROM and their infants. However, the
lack of large scale antenatal GBS screening in China may also
contribute to the low prevalence of GBS in Chinese pregnant
women. Two small sample size studies showed that the GBS posi-
tive rate in Chinese pregnant women was 9.2e15.6% [57,58].
In addition, the method of specimen collection, transportation,
and storage can also change the rate of positive cultures [59,60].
These factors may also contribute to the variance in colonized
bacteria in different areas.
Colonized bacteria lead to neonatal infection
Some studies foundmicrobiological agreement betweenwomen
with PROM and their newborns, and a further correlation between
the surface colonizationofbabies' genital bacteria andbloodcultures
[61,62]. However, others showed that surface cultures in neonates
were of limited value in diagnosis of neonatal infection [63,64].
The acquisition of certain bacteria after birth in the upper res-
piratory system, the gastrointestinal tract, and the skin is part of
normal developmental physiology. These colonizations are usually
considered beneﬁcial, but the line between normal and invasive
ﬂora may be narrow in the neonatal period [65]. Since there is still
dispute as to whether the colonized microorganisms from women
with PROM and their babies are in accordance with the pathogens
of neonatal infection, it may not be wise to choose antibiotics ac-
cording to the colonized bacteria in maternal PROM to prevent
early infection in neonates.
Table 1
Characteristics of included studies.
Study ID Duration Region Sample size Sample type Pathogen positive
(n, %)
Characteristics of patients
Gestation
(wk)
Latent period
(h)
Microorganisms isolated from mothers
Chen DW 2010 2009 East China 100 Vaginal secretions e e e
Cheng YY 1993 1990e1991 East China 57 Vaginal secretions Aerobe: 17 (29.82)
Anaerobe: 37 (64.91)
Mycoplasma: 26 (45.16)
e e
57 Placenta Aerobe: 6 (10.53)
Anaerobe: 37 (64.91)
Mycoplasma: 3 (5.26)
Hao XQ 2003 1998e2000 North China 40 Cervical secretions 40 (100) e e
He JP 1989 e Central China 24 Cervical secretions Aerobe: 14 (58.3)
Anaerobe: 22
(91.7)
e e
9 Placenta Aerobe: 3 (33.3)
Anaerobe: 4 (44.4)
Hu BM 2010 2007e2007 South China 173 Cervical secretions 65 (37.6) e e
Jiang HL 2009 2006e2007 North China 49 Cervical secretions 26 (53.06) 26e34 e
Li L 2008 2007 Southwest China 424 Cervical secretions 162 (38.21) e e
Li PT 1990 1987e1988 Central China 52 Placenta 8 (15.38) >37 1e48
Liao LJ 2008 2006e2007 South China 31 Vaginal secretions e e e
Lin SL 2009 2007e2008 East China 200 Cervical secretions,
vaginal secretions
130 (65) 35e40 >12
Liu XC 1990 1985e1987 Central China 28 Cervical secretions 21 (75.00) e 16 cases: <12
12 cases: >12
Liu XQ 2010 2005e2007 South China 1898 Cervical secretions 507 (26.7) e e
Peng SH 1997 e Central China 80 Amniotic ﬂuid 44 (55) e e
Ren H 1997 1992e1995 East China 100 Vaginal secretions 16 (16) 33e42 e
Sun LJ 2000 1998e1999 Southwest China 17 Vaginal secretions 17 (100) 37+5e41+2 e
Sun WX 2010 2008e2009 East China 70 Vaginal secretions 63 (90) 34 e
Tian Y 2005 2003 North China 5 Vaginal secretions 5 (100) 19e40+1 4e90
Wang DC 1996 1993e1994 Northwest China 24 Amniotic ﬂuid aerobe: 11 (45.8)
anaerobe: 8 (33.3)
e e
Wang J 2012 2007e2010 South China 34 Cervical secretions,
vaginal secretions
16 (47.06) 27e34 e
Wang WH 2011 2007e2009 North China 503 Cervical secretions 278 (55.3) 34+2e45+1 0.83e67
Wang YH 1992 1987e1988 East China 60 Cervical secretions aerobe: 10 (16.6)
anaerobe: 24
(40.0)
e e
Wu L 2010 2008e2009 Southwest China 30 Cervical secretions 14 (46.67) 38 ± 2 e
Wu LS 2011 2008e2009 North China 33 Amniotic ﬂuid 8 (24.24) 5 cases: < 37
28 cases: > 37
3 cases: <12
10 cases: 12e24
10 cases: 25e48
10 cases: >48
Ye XM 1997 1994e1996 Central China 67 Cervical secretions 39 (59.7) >36 >12
Amniotic ﬂuid 32 (47.2)
Zhao LJ 2011 2010e2011 South China 65 Cervical secretions 35 (53.85) 28e36+6 e
Zhao M 2005 2003 North China 41 Cervical secretions aerobe: 24 (58.32)
anaerobe: 14 (35.42)
37e41 5e67
Zhao SY 2001 1997e1999 Southwest China 57 Vaginal secretions 13 (22.81) e e
Zhao YH 2009 2008 South China 30 Amniotic ﬂuid 20 (66.7) 32.7e41.14 e
Zhao YH 2011 2007e2008 South China 34 Amniotic ﬂuid 21 (61.8) e e
Zhen XX 1985 1983 North China 103 Amniotic ﬂuid,
cervical secretions
aerobe: 56 (53.4)
anaerobe: 74 (71.8)
e e
Zhou C 2011 2010 South China 199 Amniotic ﬂuid 19 (9.55) e e
Microorganisms isolated from neonates
Dong SH 2003 e South China 23 Neonatal pharyngeal
secretions
8 (34.78) 36e43 <2 4
26 11 (42.31) 36e43 24e48
11 8 (72.77) 36e43 >48
Wei L 1996 1990e1994 Central China 54 Neonatal pharyngeal
secretions
17 (31.48) 36e43+2 17 cases: <24
23 cases: 24e48
14 cases: >48
Wu L 2008 e Southwest China 60 Neonatal pharyngeal
secretions
22 (36.7) e 22 cases: <24
27 cases: 24e48
11 cases: > 48
Wu LS 2011 2008e2009 North China 33 Neonatal pharyngeal
secretions
4 (12.12) 5 cases: <37
28 cases: >37
3 cases: <12
10 cases: 12e24
10 cases: 25e48
10 cases: >48
Yang N 2012 2007e2010 North China 3432 Neonatal blood sample 260 (7.6) 38.9 ± 1.2 312 cases: 12
1232 cases: 12e24
785 cases: 24e48
1103 cases: >48
Zhang HH 2005 e South China 50 Neonatal pharyngeal
secretions
23 (46) 36e43 21 cases: <24
19 cases: 24e48
10 cases: >48
Table 2
Quality assessment of included studies.a
Study ID Study
period
Source of
participants
Inclusion and
exclusion criteria
Specimen type and
collecting approach
Pathogen
detection
approach
Antimicrobial
susceptibility
test and approach
Completeness of
outcome data
Total
score
Quality
level
Zhen XX 1985 1 1 1 1 1 0 1 6 A
He JP 1989 0 1 1 1 1 0 1 5 B
Li PT 1990 1 1 1 1 1 0 1 6 A
Liu XC 1990 1 1 1 1 1 0 1 6 A
Wang YH 1992 1 1 1 1 1 0 1 5 B
Cheng YY 1993 1 1 1 0.5 1 0 0 4.5 C
Wang DC 1996 1 1 1 1 1 0 1 6 A
Wei L 1996 1 1 1 1 0 0 1 5 B
Peng SH 1997 0 1 1 1 1 0 1 5 B
Ren H 1997 1 1 1 0.5 0 0 0 3.5 D
Ye XM 1997 1 1 1 1 0 0 0 5 B
Sun LJ 2000 1 1 1 0.5 1 0 0 5.5 B
Zhao SY 2001 1 1 1 1 1 0 0 5 B
Dong SH 2003 0 1 1 1 0 0 0 3 D
Hao XQ 2003 1 1 1 1 0 0.5 0 5.5 B
Tian Y 2005 1 1 1 0.5 0 0 1 3.5 D
Zhang HH 2005 0 1 1 0.5 0 0 0 2.5 D
Zhao M 2005 1 1 1 1 0 0 0 4 C
Li L 2008 1 1 1 0.5 1 0 1 5.5 B
Liao LJ 2008 1 1 1 0.5 1 0 1 5.5 B
Wu L 2008 0 1 1 1 0 0 0 3 D
Jiang HL 2009 1 1 1 0.5 0 0 0 3.5 D
Lin SL 2009 1 1 1 1 1 0 0 6 A
Zhao YH 2009 1 1 1 1 1 0 1 6 A
Chen DW 2010 1 1 1 1 1 0 1 5 B
Hu BM 2010 1 1 1 0.5 0 0 0 3.5 D
Liu XQ 2010 1 1 1 1 1 1 1 7 A
Sun WX 2010 1 1 1 1 1 1 1 7 A
Wu L 2010 1 1 1 0.5 0 0 1 4.5 C
Wang WH 2011 1 1 1 1 1 0.5 1 6.5 A
Wu LS 2011 1 1 1 1 0 0 1 5 B
Zhao LJ 2011 1 1 1 0.5 0 0 0 3.5 D
Zhao YH 2011 1 1 1 1 1 0.5 1 6.5 A
Zhou C 2011 1 1 1 1 1 1 1 7 A
Wang J 2012 1 1 1 0.5 0 0 0 3.5 D
Yang N 2012 1 1 0 0.5 0 0 1 3.5 D
Average score 0.86 1 1 0.82 0.55 0.12 0.58 4.94 C
a The total score is 7 for each study. Level A: 6e7, Level B: 5e6, Level C: 4e5, and Level D: <4.
Fig. 2. Microorganisms isolated from mothers with premature rupture of the membranes, China (1980e2012).
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Fig. 3. Gram-positive microorganisms isolated from mothers with premature rupture of the membranes, China (1980e2012).
L.-n. Zeng et al. / Taiwanese Journal of Obstetrics & Gynecology 53 (2014) 443e451448Antibiotic use in PROM
Antibiotic treatment for maternal PROM
Recommendations regarding antibiotic therapy for mothers
have been presented in PPROM guidelines [1,8,66,67]. Penicillins or
macrolide antibiotics in parenteral and/or oral forms are recom-
mended. The main evidence supporting these recommendations
are two large randomized controlled trials that enrolled 614womenFig. 4. Gram-positive microorganisms isolated from mothers witand 4826 women, respectively [68,69], in addition to a Cochrane
systematic review [70]. However, a 7-year follow-up study of these
trials showed that there was no difference in long-term outcomes.
The proportion of children with any functional impairment in the
antibiotic group was the same as that in the control group [71]. In
addition, it is still unknown whether routine use of antibiotic
treatment for premature rupture of membranes at or near term is
beneﬁcial [2]. More research is needed on PROM at term.h premature rupture of the membranes, China (1980e2012).
Fig. 5. Fungus isolated from mothers with premature rupture of the membranes, China (1980e2012).
Fig. 6. Anaerobes isolated from mothers with premature rupture of the membranes, China (1980e2012).
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A Cochrane review compared prophylactic versus selective an-
tibiotics for term newborn infants with maternal risk factors for
neonatal infection [72].Table 3
Bacteria isolated from neonates with premature rupture of the membranes, China (1980
Study ID Aerobic bacteria
Gþ
Staphylococcus aureus Streptococcus Corynebacterium Other Gþ
bacteria
Wei L 1996 7 0 0 0
Wu LS 2011 2 0 1 0
Yang N 2012 132 10 0 10
Total 141 10 1 10
Aerobic bacteria 253 (Gþ: 162; G: 91).
Anaerobic bacteria 7.
Fungus 20.
G ¼ Gram.Only a small, randomized, controlled trial was included, which
evaluated the effect of giving parenteral antibiotics to neonates
born to mothers with PROM [73]. There are insufﬁcient data from
randomized controlled trials to guide clinical practice. Thus, a largee2012).
Anaerobic bacteria Fungus
G G
Enterobacter Klebsiella Other G
bacteria
Bacteroid Peptostreptococcus
3 0 0 4 3 0
0 0 0 0 0 0
33 42 13 0 0 20
36 42 13 4 3 20
Fig. 7. Strains cultured from mothers and neonates with premature rupture of the membranes in 6 regions of China (1980e2012).
L.-n. Zeng et al. / Taiwanese Journal of Obstetrics & Gynecology 53 (2014) 443e451450randomized controlled trial is needed in asymptomatic term in-
fants with maternal risk factors for neonatal infection [72]. Further,
since the spectrum of pathogens is different in China compared
with Western countries, the antibiotic chosen for prophylactic use
should also be carefully considered. Research from Taiwan showed
that early-onset E. coli sepsis in neonates wasmore likely associated
with PPROM compared with non-E. coli sepsis and 79% of the E. coli
isolates were ampicillin-resistant [74]. Therefore, studies are
needed to support the proper choice of prophylactic antibiotics for
newborns if prophylactic antibiotics are necessary.
Conclusion
The main pathogens derived from Chinese women with PROM
and their newborns are Staphylococcus and Escherichia. This differs
from the pathogens in western countries. Hence, the pathogens
involved in PROM need to be deﬁned in each country and area in
order to choose appropriate antibiotic regimens. The empiric
antibiotic selection for a certain region or country may differ from
another's based upon local bacterial pathogens. Randomized
controlled studies are needed to compare prophylactic versus se-
lective antibiotics for newborn infants with a history of PROM.
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